151. Abstract 1272: Targeting glioma stem cells through death receptor activation by AdsTRAIL
- Author
-
Frederick Lang, Yuanfang Liu, Howard Colman, Vinay K. Puduvalli, and Jihong Xu
- Subjects
Cancer Research ,biology ,medicine.disease ,Caspase 8 ,XIAP ,Oncology ,Cell culture ,Apoptosis ,Glioma ,Survivin ,Immunology ,medicine ,biology.protein ,Cancer research ,FADD ,Stem cell - Abstract
Emerging data suggests that human malignant gliomas may be sustained by the activity of a subpopulation of cells which have stem like characteristics; these glioma stem cells (GSC) exhibit resistance to conventional treatments and constitute novel targets for therapeutic strategies against these malignancies. The goal of this study was to examine whether GSC could be targeted using AdsTRAIL, an adenoviral vector expressing soluble TRAIL and to determine if AdsTRAIL effects could be potentiated by suppressing inhibitors of TRAIL-induced apoptosis. Analysis of expression of TRAIL activated death receptor pathway components showed that DR4, DR5, FADD and Caspase 8 were expressed in the majority of GSC although some cell lines expressed only one of the death receptors (DR4 or DR5). Several cell lines also showed high level of expression of survivin, an anti-apoptosis protein. Treatment of GSC, cultured as tumor spheres in stem cell medium, with AdsTRAIL resulted in dissociation of spheres into a single cell suspension and induction of apoptosis dose and time dependent manner, changes which were not seen in the AdEGFP control; no morphologic changes or induction of apoptosis was seen in GSC spheres treated with purified soluble TRAIL. To determine if induction of apoptosis by AdsTRAIL could be enhanced by suppressing inhibitors of TRAIL induced apoptosis, GSC were treated with AdXAF1, an adenoviral construct expressing XAF1, an endogenous inhibitor of XIAP, prior to exposure to AdsTRAIL. Viability was monitored by expression of the fluorescent marker EGFP in the treated cells. The combination of AdsTRAIL and AdXAF1 potently induced apoptosis to a greater degree than either agent alone. These results suggest that despite their resistance to conventional therapeutic agents such as chemotherapy and radiation, glioma stem cells could potentially be targeted by apoptosis inducing biological agents such as AdsTRAIL. Further characterization of the effects of AdsTRAIL against GSC is required to fully assess the potential of this agent against treatment resistant malignant gliomas. Note: This abstract was not presented at the AACR 101st Annual Meeting 2010 because the presenter was unable to attend. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 1272.
- Published
- 2010
- Full Text
- View/download PDF